11/8
12:31 pm
plrx
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Medium
Report
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
9/13
08:02 am
plrx
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Medium
Report
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
9/9
09:01 am
plrx
Pliant Therapeutics, Inc. (NASDAQ: PLRX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $33.00 price target on the stock.
Low
Report
Pliant Therapeutics, Inc. (NASDAQ: PLRX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $33.00 price target on the stock.
9/9
08:56 am
plrx
Rating for PLRX
Low
Report
Rating for PLRX